Assessing cancer-related cognitive function in the context of everyday life using ecological mobile cognitive testing: A protocol for a prospective quantitative study
暂无分享,去创建一个
[1] H. Okamura,et al. A scoping review of cognitive assessment tools and domains for chemotherapy-induced cognitive impairments in cancer survivors , 2023, Frontiers in Human Neuroscience.
[2] Alexandra M. Gaynor,et al. Remote, Computerised Cognitive Assessment for Breast Cancer- and Treatment-Related Cognitive Dysfunction: Psychometric Characteristics of the Cogsuite Neurocognitive Battery. , 2023, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.
[3] S. Kesler,et al. Remote assessment of cognitive dysfunction in hematologic malignancies using web‐based neuropsychological testing , 2022, Cancer medicine.
[4] Alexandra M. Gaynor,et al. Novel computerized neurocognitive test battery is sensitive to cancer-related cognitive deficits in survivors , 2022, Journal of Cancer Survivorship.
[5] Philip D. Harvey,et al. Feasibility and validity of ecological momentary cognitive testing among older adults with mild cognitive impairment , 2022, Frontiers in Digital Health.
[6] C. Nowinski,et al. Uses of the NIH Toolbox® in Clinical Samples , 2022, Neurology. Clinical practice.
[7] Raeanne C. Moore,et al. Initial Psychometric Properties of 7 NeuroUX Remote Ecological Momentary Cognitive Tests Among People With Bipolar Disorder: Validation Study , 2022, Journal of medical Internet research.
[8] C. Depp,et al. Relationships between daily mood states and real-time cognitive performance in individuals with bipolar disorder and healthy comparators: A remote ambulatory assessment study , 2021, Journal of clinical and experimental neuropsychology.
[9] C. Yuan,et al. Psychometric evaluation of the PROMIS social function short forms in Chinese patients with breast cancer , 2021, Health and Quality of Life Outcomes.
[10] N. Lunet,et al. Trajectories of cognitive performance over five years in a prospective cohort of patients with breast cancer (NEON-BC) , 2021, Breast.
[11] Y. Roquelaure,et al. Return to work of breast cancer survivors: toward an integrative and transactional conceptual model , 2021, Journal of Cancer Survivorship.
[12] A. J. van der Beek,et al. Trajectories of Cognitive Symptoms in Sick-Listed Cancer Survivors , 2021, Cancers.
[13] S. Kesler,et al. Measuring Self-Reported Cancer-Related Cognitive Impairment: Recommendations from the Cancer Neuroscience Initiative Working Group. , 2021, Journal of the National Cancer Institute.
[14] Y. T. Cheung,et al. Cancer-related cognitive impairment in patients with non-central nervous system malignancies: an overview for oncology providers from the MASCC Neurological Complications Study Group , 2020, Supportive Care in Cancer.
[15] Philip D. Harvey,et al. Remote Ecological Momentary Testing of Learning and Memory in Adults With Serious Mental Illness. , 2020, Schizophrenia bulletin.
[16] C. Parsey,et al. BrainCheck: Validation of a Computerized Cognitive Test Battery for Detection of Mild Cognitive Impairment and Dementia , 2020, medRxiv.
[17] F. André,et al. Differentiation of groups of patients with cognitive complaints at breast cancer diagnosis: Results from a sub‐study of the French CANTO cohort , 2020, Psycho-oncology.
[18] Ali Montazeri,et al. Health-related quality of life in breast cancer patients: review of reviews from 2008 to 2018 , 2020, Health and Quality of Life Outcomes.
[19] J. Grellard,et al. Perceived Cognitive Impairment in Breast Cancer Survivors and Its Relationships with Psychological Factors , 2020, Cancers.
[20] S. Kesler,et al. A randomized control trial of meditation compared to music listening to improve cognitive function for breast cancer survivors: Feasibility and acceptability. , 2020, Complementary therapies in clinical practice.
[21] Raeanne C. Moore,et al. Daily Activities Related to Mobile Cognitive Performance in Middle-Aged and Older Adults: An Ecological Momentary Cognitive Assessment Study , 2020, JMIR mHealth and uHealth.
[22] M. Fitch,et al. Going beyond (electronic) patient-reported outcomes: harnessing the benefits of smart technology and ecological momentary assessment in cancer survivorship research , 2020, Supportive Care in Cancer.
[23] Stacey B. Scott,et al. Memory lapses in daily life among breast cancer survivors and women without cancer history , 2020, Psycho-oncology.
[24] G. Winocur,et al. Cancer-Related Cognitive Impairment: An update on state of the art, detection, and management strategies in cancer survivors. , 2019, Annals of oncology : official journal of the European Society for Medical Oncology.
[25] Stacey B. Scott,et al. Cognitive performance of breast cancer survivors in daily life: Role of fatigue and depressed mood , 2019, Psycho-oncology.
[26] J. Fardell,et al. Why Are Objective and Perceived Cognitive Function Weakly Correlated in Patients With Cancer? , 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[27] D. Eagleman,et al. A Rapid, Mobile Neurocognitive Screening Test to Aid in Identifying Cognitive Impairment and Dementia (BrainCheck): Cohort Study , 2019, JMIR aging.
[28] P. Schofield,et al. Subjective, but not objective, cognitive complaints impact long-term quality of life in cancer patients , 2019, Journal of psychosocial oncology.
[29] Matthias G. Arend,et al. Statistical power in two-level models: A tutorial based on Monte Carlo simulation. , 2019, Psychological methods.
[30] D. Howieson. Current limitations of neuropsychological tests and assessment procedures , 2019, The Clinical neuropsychologist.
[31] H. Dhillon,et al. Important differences and meaningful changes for the Functional Assessment of Cancer Therapy-Cognitive Function (FACT-Cog) , 2018, Journal of Patient-Reported Outcomes.
[32] L. Minasian,et al. Longitudinal Trajectory and Characterization of Cancer-Related Cognitive Impairment in a Nationwide Cohort Study. , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[33] T. Horowitz,et al. A Call for a Neuroscience Approach to Cancer-Related Cognitive Impairment , 2018, Trends in Neurosciences.
[34] H. Dhillon,et al. Systematic review of self-reported cognitive function in cancer patients following chemotherapy treatment , 2018, Journal of Cancer Survivorship.
[35] S. Kesler,et al. Modifiable correlates of perceived cognitive function in breast cancer survivors up to 10 years after chemotherapy completion , 2018, Journal of Cancer Survivorship.
[36] T. Ahles,et al. New Challenges in Psycho‐Oncology Research IV: Cognition and cancer: Conceptual and methodological issues and future directions , 2018, Psycho-oncology.
[37] S. Kesler,et al. Predicting Long-Term Cognitive Outcome Following Breast Cancer with Pre-Treatment Resting State fMRI and Random Forest Machine Learning , 2017, Front. Hum. Neurosci..
[38] D. Eagleman,et al. Diagnostic accuracy of tablet-based software for the detection of concussion , 2017, PloS one.
[39] S. Newman,et al. Is there a relationship between objectively measured cognitive changes in patients with solid tumours undergoing chemotherapy treatment and their health‐related quality of life outcomes? A systematic review , 2017, Psycho-oncology.
[40] C. Heckler,et al. Cognitive Complaints in Survivors of Breast Cancer After Chemotherapy Compared With Age-Matched Controls: An Analysis From a Nationwide, Multicenter, Prospective Longitudinal Study. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[41] Sunita K. Patel,et al. Convergent and criterion validity of the CogState computerized brief battery cognitive assessment in women with and without breast cancer , 2017, The Clinical neuropsychologist.
[42] L. Fallowfield,et al. Patient-reported outcome measures of the impact of cancer on patients’ everyday lives: a systematic review , 2016, Journal of Cancer Survivorship.
[43] P. Ganz,et al. Subjective or Objective Measures of Cognitive Functioning-What's More Important? , 2016, JAMA oncology.
[44] J. Teresi,et al. Methodological Issues in Examining Measurement Equivalence in Patient Reported Outcomes Measures: Methods Overview to the Two-Part Series, "Measurement Equivalence of the Patient Reported Outcomes Measurement Information System® (PROMIS®) Short Forms". , 2016, Psychological test and assessment modeling.
[45] A. Saykin,et al. Reliable change in neuropsychological assessment of breast cancer survivors , 2016, Psycho-oncology.
[46] Eileen F. Tallman,et al. Perceived cognitive function in breast cancer survivors: evaluating relationships with objective cognitive performance and other symptoms using the functional assessment of cancer therapy-cognitive function instrument. , 2015, Journal of pain and symptom management.
[47] Kyle R. Noll,et al. Clinical characteristics, pathophysiology, and management of noncentral nervous system cancer‐related cognitive impairment in adults , 2015, CA: a cancer journal for clinicians.
[48] T. Marteau,et al. Executive function in the context of chronic disease prevention: theory, research and practice. , 2014, Preventive medicine.
[49] L. Mackenzie,et al. Chemobrain Experienced by Breast Cancer Survivors: A Meta-Ethnography Study Investigating Research and Care Implications , 2014, PloS one.
[50] J. Anema,et al. Physical and psychosocial problems in cancer survivors beyond return to work: a systematic review , 2014, Psycho-oncology.
[51] Shelli R. Kesler,et al. Prevalence, mechanisms, and management of cancer-related cognitive impairment , 2014, International review of psychiatry.
[52] J. Zihl,et al. Telephone-based screening tools for mild cognitive impairment and dementia in aging studies: a review of validated instruments , 2013, Front. Aging Neurosci..
[53] J. Suls,et al. New approaches to understand cognitive changes associated with chemotherapy for non-central nervous system tumors. , 2013, Journal of pain and symptom management.
[54] J. Carpenter,et al. Impact of perceived cognitive impairment in breast cancer survivors. , 2013, European journal of oncology nursing : the official journal of European Oncology Nursing Society.
[55] N. Bolger,et al. Intensive Longitudinal Methods: An Introduction to Diary and Experience Sampling Research , 2013 .
[56] A. Hutchinson,et al. Objective and subjective cognitive impairment following chemotherapy for cancer: a systematic review. , 2012, Cancer treatment reviews.
[57] P. Butow,et al. Choosing between the EORTC QLQ-C30 and FACT-G for measuring health-related quality of life in cancer clinical research: issues, evidence and recommendations. , 2011, Annals of oncology : official journal of the European Society for Medical Oncology.
[58] T. Ahles,et al. International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer. , 2011, The Lancet. Oncology.
[59] G. Velikova,et al. The Social Difficulties Inventory (SDI): development of subscales and scoring guidance for staff , 2011, Psycho-oncology.
[60] D. Boulware,et al. Patterns of care and survival in cancer patients with cognitive impairment. , 2010, Critical reviews in oncology/hematology.
[61] Oscar L. Lopez,et al. Telephone Interview for Cognitive Status , 2009, Neuroepidemiology.
[62] S. Subramanian,et al. Confronting chemobrain: an in-depth look at survivors’ reports of impact on work, social networks, and health care response , 2009, Journal of cancer survivorship : research and practice.
[63] M. Sprangers,et al. The role of neuropsychological functioning in cancer survivors' return to work one year after diagnosis , 2009, Psycho-oncology.
[64] Masumi Iida,et al. A Procedure for Evaluating Sensitivity to Within-Person Change: Can Mood Measures in Diary Studies Detect Change Reliably? , 2006, Personality & social psychology bulletin.
[65] A. Cull,et al. Development and evaluation of an instrument to assess social difficulties in routine oncology practice , 2005, Quality of Life Research.
[66] D. Tulsky,et al. The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[67] Philip D. Harvey,et al. Capturing Clinical Symptoms with Ecological Momentary Assessment: Convergence of Momentary Reports of Psychotic and Mood Symptoms with Diagnoses and Standard Clinical Assessments. , 2021, Innovations in clinical neuroscience.
[68] J. Teresi,et al. Measurement Equivalence of the Patient Reported Outcomes Measurement Information System® (PROMIS®) Applied Cognition - General Concerns, Short Forms in Ethnically Diverse Groups. , 2016, Psychological test and assessment modeling.